Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes, CLC Bio Ink Licensing Pact

NEW YORK (GenomeWeb News) – ImaGenes will provide its next-generation sequencing customers with a license to CLC Bio’s Genomics Workbench for sequence analysis applications under a new bundling agreement, CLC Bio said today.

ImaGenes Director of Bioinformatics and Services Steffen Henning said in a statement that the firm sought "a software platform which we could use to present our research results to our customers in an easy, coherent, and user-friendly way," and which would function with various next-generation sequencing platforms.

The bundling agreement enables ImaGenes to provide all of its customers who receive next-generation sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.